Davallia Divaricata BL: The Use of Traditional Chinese Native Medicine for Osteoporosis

Osteoporosis Clinical Trial

Official title:

The Use Tradition Chinese Native Medicine Treats the Osteoporosis Research

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00154609
• Other study ID #: 930701
• Status: Recruiting
• Phase: Phase 1
• First received: September 9, 2005
• Last updated: January 20, 2006
• Start date: January 2002

Study information

• Verified date: January 2002
• Source: National Taiwan University Hospital
• Contact: Liu Hwa-Chang, Ph.D
• Phone: 886-2-23956988
• Email: hcliu[@]ha.mc.ntu.edu.tw
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Interventional

Clinical Trial Summary

We, the investigators at National Taiwan University Hospital, have determined the therapeutic and toxic effects of the traditional herb on the ovariectomized Wistar rat.

The final years will determine its effects on the therapy of women who are over 45 years old and postmenopausal with osteoporosis.

Description:

Research of this traditional chinese clinical medicine, Gusuibu, curative effect is planned for three years time. The entire study aims to evaluate the effect of the traditional chinese medicine on postmenopausal osteoporosis as well as the possible side effects on the experimental animal and the human body. All subjects were postmenopausal women with established osteoporosis.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 45 Years to 70 Years

Eligibility

Inclusion Criteria:

• Postmenopausal osteoporosis

Exclusion Criteria:

• Insulin dependent diabetes

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Osteoporosis

Intervention

Drug:
• Gu-Sui-Bu (Davallia Divaricata)

Locations

Country	Name	City	State
Taiwan	National Taiwan University Medical Center	Taipei	7, Chung-Shan South Road

Sponsors (1)

Lead Sponsor	Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The project is aimed to investigate the clinical effects of the water extract of Gu-Sui-Bu from the aspects of animal and clinic studies.